Searched by
Class I
1 2
Clip | Code No. | Product | Data | |||
---|---|---|---|---|---|---|
Data
Sheet |
Category | Conjugate | MHC Allele | Size | Availability | |
Sequence | Location (aa) | Storage
temp. |
||||
|
||||||
TB-0146-1 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-PE |
|||||
virus EBV |
PE | A*02:01 | 50 tests |
0 (Contact us) |
||
YLLEMLWRL | 125-133 | 4°C | ||||
TB-0173-1 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-PE |
|||||
virus HPV |
PE | A*02:01 | 50 tests |
0 (Contact us) |
||
MLDLQPETT | 12-20 | 4°C | ||||
TB-0131-1 |
HLA-A*02:01 EBV BALF4 Tetramer-FLDKGTYTL-PE |
|||||
virus EBV |
PE | A*02:01 | 50 tests |
0 (Contact us) |
||
FLDKGTYTL | 276-284 | 4°C | ||||
TB-0173-2 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-APC |
|||||
virus HPV |
APC | A*02:01 | 50 tests |
0 (Contact us) |
||
MLDLQPETT | 12-20 | 4°C | ||||
TB-5110-1 |
H-2Kb HBV HBsAg Tetramer-VWLSVIWM-PE |
|||||
virus HBV |
PE | H-2Kb | 50 tests |
0 (Contact us) |
||
VWLSVIWM | 190-197 | 4°C | ||||
TB-0173-4 |
HLA-A*02:01 HPV16 E7 Tetramer-MLDLQPETT-BV421 |
|||||
virus HPV |
BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
MLDLQPETT | 12-20 | 4°C | ||||
TB-5110-4 |
H-2Kb HBV HBsAg Tetramer-VWLSVIWM-BV421 |
|||||
virus HBV |
BV421 | H-2Kb | 50 tests |
0 (Contact us) |
||
VWLSVIWM | 190-197 | 4°C | ||||
TB-0143-1 |
HLA-B*07:02 HPV E7 Tetramer-KPTLKEYVL-PE |
|||||
virus HPV |
PE | B*07:02 | 50 tests |
0 (Contact us) |
||
KPTLKEYVL | 5-13 | 4°C | ||||
TB-0143-4 |
HLA-B*07:02 HPV E7 Tetramer-KPTLKEYVL-BV421 |
|||||
virus HPV |
BV421 | B*07:02 | 50 tests |
0 (Contact us) |
||
KPTLKEYVL | 5-13 | 4°C | ||||
TB-0143-2 |
HLA-B*07:02 HPV E7 Tetramer-KPTLKEYVL-APC |
|||||
virus HPV |
APC | B*07:02 | 50 tests |
0 (Contact us) |
||
KPTLKEYVL | 5-13 | 4°C | ||||
TB-5110-2 |
H-2Kb HBV HBsAg Tetramer-VWLSVIWM-APC |
|||||
virus HBV |
APC | H-2Kb | 50 tests |
0 (Contact us) |
||
VWLSVIWM | 190-197 | 4°C | ||||
TB-0148-4 |
HLA-B*27:05 HIV env Tetramer-GRAFVTIGK-BV421 |
|||||
virus HIV |
BV421 | B*27:05 | 50 tests |
0 (Contact us) |
||
GRAFVTIGK | 103-111 | 4°C | ||||
TB-0157-1 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
RMPEAAPPV | 65-73 | 4°C | ||||
TB-0170-1 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-PE |
|||||
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
KLQVFLIVL | 5-13 | 4°C | ||||
TB-0132-1 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
FLYDDNQRV | 828-836 | 4°C | ||||
TB-0167-1 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-PE |
|||||
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
||
RYCNLEGPPI | 177-186 | 4°C | ||||
TB-0140-2 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-APC |
|||||
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
||
EYILSLEEL | 298-306 | 4°C | ||||
TB-0164-2 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
YMCSFLFNL | 666-674 | 4°C | ||||
TB-0157-4 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
RMPEAAPPV | 65-73 | 4°C | ||||
TB-0129-2 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-APC |
|||||
cancer | APC | B*35:01 | 50 tests |
0 (Contact us) |
||
MPFATPMEA | 94-102 | 4°C | ||||
TB-0119-4 |
HLA-B*07:02 Tyrosinase Tetramer-LPWHRLFLL-BV421 |
|||||
cancer | BV421 | B*07:02 | 50 tests |
0 (Contact us) |
||
LPWHRLFLL | 208-216 | 4°C | ||||
TB-0167-4 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-BV421 |
|||||
cancer | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
RYCNLEGPPI | 177-186 | 4°C | ||||
TB-0161-4 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
VLAGGFFLL | 27-38 | 4°C | ||||
TB-0157-2 |
HLA-A*02:01 p53 Tetramer-RMPEAAPPV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
RMPEAAPPV | 65-73 | 4°C | ||||
TB-0148-2 |
HLA-B*27:05 HIV env Tetramer-GRAFVTIGK-APC |
|||||
virus HIV |
APC | B*27:05 | 50 tests |
0 (Contact us) |
||
GRAFVTIGK | 103-111 | 4°C | ||||
TB-5112-1 |
H-2Ld MTB Ag85A Tetramer-MPVGGQSSF-PE |
|||||
bacteria | PE | H-2Ld | 50 tests |
0 (Contact us) |
||
MPVGGQSSF | 70-78 | 4°C | ||||
TB-5109-4 |
H-2Db MCMV M45 Tetramer-HGIRNASFI-BV421 |
|||||
virus | BV421 | H-2Db | 50 tests |
0 (Contact us) |
||
HGIRNASFI | 985-993 | 4°C | ||||
TB-5109-2 |
H-2Db MCMV M45 Tetramer-HGIRNASFI-APC |
|||||
virus | APC | H-2Db | 50 tests |
0 (Contact us) |
||
HGIRNASFI | 985-993 | 4°C | ||||
TB-0167-2 |
HLA-A*24:02 LY6K Tetramer-RYCNLEGPPI-APC |
|||||
cancer | APC | A*24:02 | 50 tests |
0 (Contact us) |
||
RYCNLEGPPI | 177-186 | 4°C | ||||
TB-0162-1 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-PE |
|||||
Others | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
VLFGLGFAI | 265-273 | 4°C | ||||
TB-0138-1 |
HLA-A*03:01 HIV Nef Tetramer-QVPLRPMTYK-PE |
|||||
virus HIV |
PE | A*03:01 | 50 tests |
0 (Contact us) |
||
QVPLRPMTYK | 73-82 | 4°C | ||||
TB-0133-4 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-BV421 |
|||||
virus HTLV |
BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
AVLDGLLSL | 42-50 | 4°C | ||||
TB-0152-2 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
KLCPVQLWV | 139-147 | 4°C | ||||
TB-0140-1 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-PE |
|||||
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
||
EYILSLEEL | 298-306 | 4°C | ||||
TB-0135-4 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-BV421 |
|||||
virus HIV |
BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
GLADQLIHL | 101-109 | 4°C | ||||
TB-0130-1 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-PE |
|||||
virus HIV |
PE | A*24:02 | 50 tests |
0 (Contact us) |
||
RYLKDQQLL | 67-75 | 4°C | ||||
TB-0127-2 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
AILALLPAL | 105-133 | 4°C | ||||
TB-5111-1 |
H-2Dd MCMV M164 Tetramer-AGPPRYSRI-PE |
|||||
virus | PE | H-2Dd | 50 tests |
0 (Contact us) |
||
AGPPRYSRI | 257-265 | 4°C | ||||
TB-5108-2 |
H-2Db Survivin Tetramer-ATFKNWPFL-APC |
|||||
cancer | APC | H-2Db | 50 tests |
0 (Contact us) |
||
ATFKNWPFL | 20-28 | 4°C | ||||
TB-0162-4 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-BV421 |
|||||
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
VLFGLGFAI | 265-273 | 4°C | ||||
TB-0162-2 |
HLA-A*02:01 IGRP Tetramer-VLFGLGFAI-APC |
|||||
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
VLFGLGFAI | 265-273 | 4°C | ||||
TB-0159-2 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
SLPPPGTRV | 149-157 | 4°C | ||||
TB-0158-2 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
SLFLGILSV | 188-196 | 4°C | ||||
TB-0152-1 |
HLA-A*02:01 p53 Tetramer-KLCPVQLWV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
KLCPVQLWV | 139-147 | 4°C | ||||
TB-0148-1 |
HLA-B*27:05 HIV env Tetramer-GRAFVTIGK-PE |
|||||
virus HIV |
PE | B*27:05 | 50 tests |
0 (Contact us) |
||
GRAFVTIGK | 103-111 | 4°C | ||||
TB-0147-4 |
HLA-B*08:01 CMV IE1 Tetramer-QIKVRVDMV-BV421 |
|||||
virus CMV |
BV421 | B*08:01 | 50 tests |
0 (Contact us) |
||
QIKVRVDMV | 88-96 | 4°C | ||||
TB-0147-1 |
HLA-B*08:01 CMV IE1 Tetramer-QIKVRVDMV-PE |
|||||
virus CMV |
PE | B*08:01 | 50 tests |
0 (Contact us) |
||
QIKVRVDMV | 88-96 | 4°C | ||||
TB-0146-4 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-BV421 |
|||||
virus EBV |
BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
YLLEMLWRL | 125-133 | 4°C | ||||
TB-0132-4 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
FLYDDNQRV | 828-836 | 4°C | ||||
TB-0130-4 |
HLA-A*24:02 HIV env Tetramer-RYLKDQQLL-BV421 |
|||||
virus HIV |
BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
RYLKDQQLL | 67-75 | 4°C | ||||
TB-0129-1 |
HLA-B*35:01 NY-ESO-1 Tetramer-MPFATPMEA-PE |
|||||
cancer | PE | B*35:01 | 50 tests |
0 (Contact us) |
||
MPFATPMEA | 94-102 | 4°C | ||||
TB-0127-1 |
HLA-A*02:01 PSCA Tetramer-AILALLPAL-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
AILALLPAL | 105-133 | 4°C | ||||
TB-0126-1 |
HLA-A*01:01 Tyrosinase Tetramer-KSDICTDEY-PE |
|||||
cancer | PE | A*01:01 | 50 tests |
0 (Contact us) |
||
KSDICTDEY | 243-251 | 4°C | ||||
TB-5111-2 |
H-2Dd MCMV M164 Tetramer-AGPPRYSRI-APC |
|||||
virus | APC | H-2Dd | 50 tests |
0 (Contact us) |
||
AGPPRYSRI | 257-265 | 4°C | ||||
TB-5109-1 |
H-2Db MCMV M45 Tetramer-HGIRNASFI-PE |
|||||
virus | PE | H-2Db | 50 tests |
0 (Contact us) |
||
HGIRNASFI | 985-993 | 4°C | ||||
TB-5108-4 |
H-2Db Survivin Tetramer-ATFKNWPFL-BV421 |
|||||
cancer | BV421 | H-2Db | 50 tests |
0 (Contact us) |
||
ATFKNWPFL | 20-28 | 4°C | ||||
TB-5108-1 |
H-2Db Survivin Tetramer-ATFKNWPFL-PE |
|||||
cancer | PE | H-2Db | 50 tests |
0 (Contact us) |
||
ATFKNWPFL | 20-28 | 4°C | ||||
TB-0170-2 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-APC |
|||||
Others | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
KLQVFLIVL | 5-13 | 4°C | ||||
TB-0158-4 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
SLFLGILSV | 188-196 | 4°C | ||||
TB-0151-4 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
GLQHWVPEL | 97-106 | 4°C | ||||
TB-0151-2 |
HLA-A*02:01 BA46 Tetramer-GLQHWVPEL-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
GLQHWVPEL | 97-106 | 4°C | ||||
TB-0150-4 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
GLLGASVLGL | 674-683 | 4°C | ||||
TB-0150-1 |
HLA-A*02:01 hTERT Tetramer-GLLGASVLGL-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
GLLGASVLGL | 674-683 | 4°C | ||||
TB-0140-4 |
HLA-A*24:02 GPC3 Tetramer-EYILSLEEL-BV421 |
|||||
cancer | BV421 | A*24:02 | 50 tests |
0 (Contact us) |
||
EYILSLEEL | 298-306 | 4°C | ||||
TB-0137-4 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-BV421 |
|||||
virus HPV |
BV421 | A*03:01 | 50 tests |
0 (Contact us) |
||
KLCLRFLSK | 64-72 | 4°C | ||||
TB-0137-1 |
HLA-A*03:01 HPV E6 Tetramer-KLCLRFLSK-PE |
|||||
virus HPV |
PE | A*03:01 | 50 tests |
0 (Contact us) |
||
KLCLRFLSK | 64-72 | 4°C | ||||
TB-0136-2 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
GLAPPQHLIRV | 187-197 | 4°C | ||||
TB-0136-1 |
HLA-A*02:01 p53 Tetramer-GLAPPQHLIRV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
GLAPPQHLIRV | 187-197 | 4°C | ||||
TB-0133-2 |
HLA-A*02:01 HTLV bZIP Tetramer-AVLDGLLSL-APC |
|||||
virus HTLV |
APC | A*02:01 | 50 tests |
0 (Contact us) |
||
AVLDGLLSL | 42-50 | 4°C | ||||
TB-0124-2 |
HLA-B*27:05 HIV gag Tetramer-KRWIILGLNK-APC |
|||||
virus HIV |
APC | B*27:05 | 50 tests |
0 (Contact us) |
||
KRWIILGLNK | 265-274 | 4°C | ||||
TB-0163-2 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
YLGSYGFRL | 103-111 | 4°C | ||||
TB-0156-2 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
QLCPICRAPV | 175-184 | 4°C | ||||
TB-0146-2 |
HLA-A*02:01 EBV LMP1 Tetramer-YLLEMLWRL-APC |
|||||
virus EBV |
APC | A*02:01 | 50 tests |
0 (Contact us) |
||
YLLEMLWRL | 125-133 | 4°C | ||||
TB-0142-2 |
HLA-B*07:02 HIV gag Tetramer-GPGHKARVL-APC |
|||||
virus HIV |
APC | B*07:02 | 50 tests |
0 (Contact us) |
||
GPGHKARVL | 223?231 | 4°C | ||||
TB-0142-1 |
HLA-B*07:02 HIV gag Tetramer-GPGHKARVL-PE |
|||||
virus HIV |
PE | B*07:02 | 50 tests |
0 (Contact us) |
||
GPGHKARVL | 223?231 | 4°C | ||||
TB-0139-1 |
HLA-A*24:02 PSA Tetramer-CYASGWGSI-PE |
|||||
cancer | PE | A*24:02 | 50 tests |
0 (Contact us) |
||
CYASGWGSI | 153-161 | 4°C | ||||
TB-0135-2 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-APC |
|||||
virus HIV |
APC | A*02:01 | 50 tests |
0 (Contact us) |
||
GLADQLIHL | 101-109 | 4°C | ||||
TB-0135-1 |
HLA-A*02:01 HIV Vif Tetramer-GLADQLIHL-PE |
|||||
virus HIV |
PE | A*02:01 | 50 tests |
0 (Contact us) |
||
GLADQLIHL | 101-109 | 4°C | ||||
TB-0132-2 |
HLA-A*02:01 topo II Tetramer-FLYDDNQRV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
FLYDDNQRV | 828-836 | 4°C | ||||
TB-0155-1 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
LTLGEFLKL | 96-104 | 4°C | ||||
TB-0153-1 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
LLLTVLTVV | 13-21 | 4°C | ||||
TB-0170-4 |
HLA-A*02:01 IAPP Tetramer-KLQVFLIVL-BV421 |
|||||
Others | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
KLQVFLIVL | 5-13 | 4°C | ||||
TB-0163-1 |
HLA-A*02:01 p53 Tetramer-YLGSYGFRL-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
YLGSYGFRL | 103-111 | 4°C | ||||
TB-0158-1 |
HLA-A*02:01 CD20 Tetramer-SLFLGILSV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
SLFLGILSV | 188-196 | 4°C | ||||
TB-0156-4 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
QLCPICRAPV | 175-184 | 4°C | ||||
TB-0134-2 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
FVGEFFTDV | 144-152 | 4°C | ||||
TB-0124-4 |
HLA-B*27:05 HIV gag Tetramer-KRWIILGLNK-BV421 |
|||||
virus HIV |
BV421 | B*27:05 | 50 tests |
0 (Contact us) |
||
KRWIILGLNK | 265-274 | 4°C | ||||
TB-0124-1 |
HLA-B*27:05 HIV gag Tetramer-KRWIILGLNK-PE |
|||||
virus HIV |
PE | B*27:05 | 50 tests |
0 (Contact us) |
||
KRWIILGLNK | 265-274 | 4°C | ||||
TB-0155-4 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
LTLGEFLKL | 96-104 | 4°C | ||||
TB-0155-2 |
HLA-A*02:01 Survivin Tetramer-LTLGEFLKL-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
LTLGEFLKL | 96-104 | 4°C | ||||
TB-0153-4 |
HLA-A*02:01 MUC1 Tetramer-LLLTVLTVV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
LLLTVLTVV | 13-21 | 4°C | ||||
TB-5112-4 |
H-2Ld MTB Ag85A Tetramer-MPVGGQSSF-BV421 |
|||||
bacteria | BV421 | H-2Ld | 50 tests |
0 (Contact us) |
||
MPVGGQSSF | 70-78 | 4°C | ||||
TB-5111-4 |
H-2Dd MCMV M164 Tetramer-AGPPRYSRI-BV421 |
|||||
virus | BV421 | H-2Dd | 50 tests |
0 (Contact us) |
||
AGPPRYSRI | 257-265 | 4°C | ||||
TB-0169-4 |
HLA-A*02:01 BCR-ABL Tetramer-GVRGRVEEI-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
GVRGRVEEI | bcr-abl fusion protein | 4°C | ||||
TB-0164-1 |
HLA-A*02:01 EZH2 Tetramer-YMCSFLFNL-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
YMCSFLFNL | 666-674 | 4°C | ||||
TB-0161-2 |
HLA-A*02:01 PSMA Tetramer-VLAGGFFLL-APC |
|||||
cancer | APC | A*02:01 | 50 tests |
0 (Contact us) |
||
VLAGGFFLL | 27-38 | 4°C | ||||
TB-0159-4 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
SLPPPGTRV | 149-157 | 4°C | ||||
TB-0159-1 |
HLA-A*02:01 p53 Tetramer-SLPPPGTRV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
SLPPPGTRV | 149-157 | 4°C | ||||
TB-0156-1 |
HLA-A*02:01 LIVIN Tetramer-QLCPICRAPV-PE |
|||||
cancer | PE | A*02:01 | 50 tests |
0 (Contact us) |
||
QLCPICRAPV | 175-184 | 4°C | ||||
TB-0134-4 |
HLA-A*02:01 GPC3 Tetramer-FVGEFFTDV-BV421 |
|||||
cancer | BV421 | A*02:01 | 50 tests |
0 (Contact us) |
||
FVGEFFTDV | 144-152 | 4°C |
1 2